Luis Tobalina

6PUBLICATIONS
25CO-AUTHORS
Molecular targetsPredictive and prognostic markersAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 03, 2026
Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer.

Melissa L Johnson, Giulia Fabbri, Carmela Ciardullo

|Aug 11, 2025
Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer.

Carmela Ciardullo, Luis Tobalina, T Hedley Carr

|Feb 15, 2022
Patient-specific Boolean models of signalling networks guide personalised treatments.

Arnau Montagud, Jonas Béal, Luis Tobalina

|Dec 19, 2020
SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.

Claudia Winkler, Joshua Armenia, Gemma N Jones

|Sep 08, 2017
An in-silico approach to predict and exploit synthetic lethality in cancer metabolism.

Iñigo Apaolaza, Edurne San José-Eneriz, Luis Tobalina

Pageof 1